Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum

D Pereira, B Kővári, I Brown, P Chaves… - …, 2021 - Wiley Online Library
The increasing use of gastrointestinal endoscopic procedures has led to the recognition by
histopathologists of non‐conventional (or special‐type) dysplasias of the gastrointestinal …

Endoscopic Management of Esophageal Cancer

C Paiji, A Sedarat - Cancers, 2022 - mdpi.com
Simple Summary Esophageal cancer is a leading cause of cancer-related mortality
worldwide. With ongoing innovation in endoscopy and improved understanding of this …

[HTML][HTML] The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study

R Phillips, W Januszewicz, ND Pilonis… - Gastrointestinal …, 2021 - Elsevier
Background and Aims Current understanding of the risk of neoplastic progression in patients
with Barrett's esophagus with indefinite dysplasia (BE-IND) stems from small retrospective …

[HTML][HTML] Current management of Barrett esophagus and esophageal adenocarcinoma

T Singh, V Sanghi, PN Thota - Cleveland Clinic journal of medicine, 2019 - ncbi.nlm.nih.gov
Barrett esophagus is found in 5% to 15% of patients with gastroesophageal reflux disease
and is a precursor of esophageal adenocarcinoma, yet the condition often goes …

[HTML][HTML] LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR …

S Han, DE Low - ABCD. Arquivos Brasileiros de Cirurgia Digestiva …, 2022 - SciELO Brasil
Barrett's esophagus (BE) represents the morphological premalignant manifestation of
gastroesophageal reflux disease (GERD), which develops as a consequence of the …

EsoDetect: Computational Validation and Algorithm Development of a Novel Diagnostic and Prognostic Tool for Dysplasia in Barrett's Esophagus

M Miskinyte, B Pondeca, JB Pereira-Leal, J Cardoso - medRxiv, 2024 - medrxiv.org
Barrett's esophagus (BE) is the only known precursor to esophageal adenocarcinoma
(EAC), a malignancy with increasing incidence and unfavorable prognosis. This study …

[HTML][HTML] Development of Bio-artificial Esophageal Tissue Engineering Utilization for Circumferential Lesion Transplantation: A Narrative Review

M Haghdel, MH Imanieh, H Hosseinpour… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
The esophagus is the gastrointestinal tract's primary organ that transfers bolus into the
stomach with peristaltic motion. Therefore, its lesions cause a significant disturbance in the …

[HTML][HTML] Detection and surveillance of neoplastic lesions of the esophagus: application of guidelines and techniques

K Sachdeva, L Dhaliwal, PG Iyer - Annals of Laparoscopic and …, 2023 - ales.amegroups.org
Esophageal cancer is the eighth most common cancer in the world, with high mortality rates.
The two main histological subtypes of esophageal cancer are esophageal adenocarcinoma …

Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia

X Chen, BL Liu, N Harpaz, H Zhu… - …, 2023 - Wiley Online Library
The aim of this study was to investigate the role of immunohistochemical (IHC) expression of
p53 and other potential clinical parameters as prognostic markers for predicting neoplastic …

[PDF][PDF] Markery różnicujące dysplazję w przełyku Barretta i raka gruczołowego przełyku

A Mor, K Kobus, U Leszczyńska… - Postępy Higieny i …, 2019 - ppm.umb.edu.pl
Jedynym znanym prekursorem gruczolakoraka przełyku (EAC) jest przełyk Barretta (BE). Ta
zmiana przednowotworowa może ulegać transformacji do dysplazji małego stopnia i …